
Post-Ablation Visual Auras a Sign of Transient Brain Injury?
New evidence suggests these auras may stem not from the puncture itself but from acute, procedure-related brain emboli affecting the visual cortex.
Gregory Marcus, MD, MAS
'These research findings have two distinct clinically relevant implications,' senior author Gregory Marcus, MD, MAS, cardiac electrophysiologist and endowed professor of atrial fibrillation research, University of California San Francisco (UCSF), told Medscape Medical News .
'First, they suggest that migraine symptoms with visual auras are less likely to be due to shunting of some neuroactive compound across interatrial septal defects and more likely occur as a result of occlusion of blood flow due to brain emboli,' Marcus said.
'Second, these findings demonstrate that, contrary to a long-held belief that these post-ablation MRI-detected small brain lesions are asymptomatic — in fact, they are often referred to as 'asymptomatic cerebral emboli' or 'ACEs' — these small acute brain lesions actually can, and perhaps often do, manifest in clinical symptoms,' he added.
'This finding could change the whole paradigm of treatment, perhaps focusing more on prevention of blood clots,' he added in a statement.
The study was published online on July 7 in the journal Heart Rhythm .
Brain Injury From Catheter Ablation?
The TRAVERSE trial enrolled 146 adults undergoing catheter ablation for ventricular arrhythmias; 74 were randomly allocated to ventricular access via transeptal puncture (creating a new, temporary hole between the left and right atria) and 72 to a retrograde approach (through the aortic valve, not requiring transseptal puncture).
All patients underwent high-resolution brain MRI the day after ablation and 63 (85%) in the transseptal group and 57 (79%) in the retrograde group completed a validated migraine questionnaire, a median of 38 days after the procedure.
There was no difference in post-ablation visual auras between the transseptal and retrograde aortic approaches (16% and 14%, respectively).
However, significantly more patients with acute brain emboli in the occipital or parietal lobes reported migraine-related visual auras (38% vs 11%; P < .01).
After multivariable adjustment, the presence of acute brain emboli in the occipital or parietal lobes was associated with a 12-fold greater likelihood of visual auras.
The data show that these post-ablation brain lesions are not 'clinically silent,' first author Adi Elias, MD, cardiac electrophysiology fellow at UCSF, noted in the statement. 'It may be the case that we haven't known what to look for and assessed for symptoms immediately without enough time for the subsequent visual auras that would occur,' Elias said.
Marcus elaborated on this point. He noted that prior studies have demonstrated that these small post-catheter ablation MRI-detected lesions can no longer be detected upon repeat imaging about a month later, demonstrating that the ability to detect these brain emboli is fleeting.
'Prior studies failed to demonstrate a relationship between migraine with visual aura and acute brain emboli, but perhaps they were too late to detect ephemeral MRI findings because the MRI had to be ordered and performed after symptoms develop,' Marcus said.
The TRAVERSE study is 'unique in that everyone had a brain MRI immediately after their catheter ablation procedure and likely in most, if not all cases, prior to the development of their visual aura symptoms,' he noted.
Importantly, said the researchers, the presence of brain emboli and visual auras was not associated with any significant change in cognition. Marcus said patients can be reassured that procedure-related brain emboli and visual auras typically fade within a month of the procedure.
An Under-Recognized Condition
Reached for comment, Mina Chung, MD, president of the Heart Rhythm Society, who wasn't involved in the study, told Medscape Medical News the occurrence of visual auras after ablation may be 'under-recognized.'
The fact that a prior history of visual auras was associated with visual auras at 1 month after the procedure, 'suggests some preexisting tendency toward such symptoms after these procedures,' said Chung, with the Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland.
'Reassuringly, there were no detectable differences in neurocognitive function,' said Chung.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the 'Company') (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the second quarter 2025 ending June 30, 2025 on Monday August 4, 2025 after the close of the US market. The publication will be followed by an investor conference call and webcast on Tuesday August 5, 2025 at 8:00 AM ET / 2:00 PM CET. The call will include the Company's second quarter results and an update on business activities. Details for the call are as follows: Dial in information: Domestic: +1-800-343-5172 International: +1-203-518-9856 Conference ID: CLLSQ2 Webcast Link: About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company utilizes an allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to develop gene therapies in other therapeutic indications. With its in-house manufacturing capabilities, Cellectis is one of the few end-to-end gene editing companies that controls the cell and gene therapy value chain from start to finish. Cellectis' headquarters are in Paris, France, with locations in New York and Raleigh, NC. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more, visit and follow Cellectis on LinkedIn and X. TALEN® is a registered trademark owned by Cellectis. For further information on Cellectis, please contact: Media contacts: Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@ Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93 Investor Relations contact: Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@ Attachment 20250728_Q2 2025 earnings call announcement_ENGLISHError while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data


Gizmodo
18 minutes ago
- Gizmodo
Nuclear Winter Would Be Even Worse Than We Thought
Despite happening (thankfully) just once in real life, nuclear warfare has long been a staple element of science fiction. Popular depictions of nuclear conflict—from biographic thrillers like Oppenheimer to imagined disasters like The Day After—reflect the understanding that its consequences would be irreversible and catastrophic to modern society. Unsurprisingly, nuclear warfare and its potential repercussions concern scientists as much as fiction writers. In a recent paper published in Environmental Research Letters, researchers at Pennsylvania State University examined how nuclear war might disrupt food security worldwide, focusing specifically on the global production of corn, the most produced grain crop in the world. In the worst-case scenario, nuclear weapons would wreak havoc on our atmospheric systems, gradually cutting our annual corn production by up to 87%, the study warns. For their simulations, the authors considered 38,572 locations for corn production across six different nuclear war scenarios of increasing severity. The simulations took place under nuclear winter conditions, a hypothetical climate scenario following a large-scale nuclear war. During nuclear winters, black carbon from fires triggered by nuclear detonations would fill up the sky, obstructing sunlight. The resulting drop in global temperatures could last for over a decade—long enough to decimate agricultural systems worldwide, according to the scientists. In addition to black carbon, the authors examined the potential UV-B radiation exposure to plants. The Earth's ozone usually blocks this type of radiation, but this protective layer would be weakened in the wake of nuclear war. As UV-B radiation causes DNA damage and obstructs plant photosynthesis, the researchers modeled how overexposure to this energy source could affect the soil-plant-atmosphere system that drives crop growth. The results were disturbing. First, the 'best-case scenario,' a regional nuclear war, would release enough soot into the atmosphere to reduce annual corn production by 7%—which, to be clear, would severely impact the global food system, study lead author and meteorologist Yuning Shi explained in a press release. A global-scale war, on the other hand, would inject a massive 165 million tons of soot into the atmosphere, curbing global corn production by a whopping 80%. That wasn't all; radiation damage 'would peak in years 8 and 9' following the initial detonation of the bomb, causing an additional 7% decrease in corn yields, according to the paper. 'The blast and fireball of atomic explosions produce nitrogen oxides in the stratosphere,' Shi explained. This, in combination with heat-absorbing soot, injects a fiery cycle into the atmosphere that 'rapidly [destroys] ozone, increasing UV-B radiation levels at the Earth's surface.' Thankfully, these are just simulations. They nevertheless 'force us to realize the fragility of the biosphere—the totality of all living things and how they interact with one another and the environment,' Shi said. What's more, the study acts as an early precursor to a more refined, effective response plan for potential disasters, he added. Hopefully, that disaster won't be nuclear—though it could be something like a volcanic eruption, which obstructs sunlight in a similar way and is something we can better prepare for. For example, the paper recommended preparing 'agricultural resilience kits' containing seeds for crops that can grow under cooler conditions. 'These kits would help sustain food production during the unstable years following a nuclear war, while supply chains and infrastructure recover,' said Armen Kemanian, an environmental systems expert and paper senior author, in the same release. But these kits could easily assist food security in areas affected by severe volcanic activity, he added. Natural disasters are beyond our control, save for the preparatory part. A self-inflicted environmental catastrophe and global-scale famine—that's clearly another story. When it comes to nuclear winter, the 'best approach to preventing its devastating effects is to avoid it,' the scientists wrote.


Medscape
18 minutes ago
- Medscape
Medscape 2050: Adam Rodman
Medscape 2050: The Future of Medicine There will come a day, predicts Adam Rodman, MD, a general internist and medical educator at Beth Israel Deaconess Medical Center and assistant professor at Harvard Medical School, when AI systems change disease. That's the day when they can not only diagnose diseases more accurately than humans, but define diseases in ways that only machines can understand. Take heart attacks, for example. Rodman hopes cardiologists will forgive him for pointing out that AI can already detect blocked coronary arteries from an EKG in ways that humans can't. In the not-too-distant future, Rodman believes, medicine will begin redefining more diseases and treatments that are simply not understandable by the human brain. That day isn't here yet, Rodman explains, because today's AI systems are still pretty similar to us. 'They're trained on a human understanding of disease,' he says, 'so even the best models are following the guidelines that we give them.' They mimic human reasoning, albeit a lot faster and using a lot more data. But as new AI models develop, we could reach what Rodman calls 'a nonhuman nosology': our clinical reasoning vs a machines-only thought process. And what happens when those disagree? What does it mean — for both doctors and patients — to trust a computer that we can't understand? Is this the day when doctors are out of a job? Rodman doesn't think so. Because medicine is about more than computation. There are relationships and procedures that can't be replaced. But certain areas of clinical practice will certainly change. 'If you have a job where you can sit down at a computer and interpret most of the data that has already been collected for you to make a decision,' he says, you should start looking over your shoulder. Medicine is going through an 'epistemic shift,' Rodman says, where the parameters of how we think are changing, so it's hard to predict what will come next. But we should all get ready.